Skip to Content
  • Letter
  • Open Access

17 May 2022

3 Pages

Ad Hoc Afatinib in an Eldery Lung Cancer Patient with EGFR Exon 19 Deletion L747-A750>P

,
,
,
,
,
,
and
1
Medical Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy
2
Thoracic Surgery Unit, Azienda Ospedaliera Santa Maria, via Tristano di Joannucci, 05100 Terni, Italy
3
Université Paris-Saclay, Institut Gustave Roussy, Inserm, Biomarqueurs prédictifs et nouvelles stratégies thérapeutiques en oncologie, Villejuif, France
4
Division of Pathology, Azienda Ospedaliera Santa Maria, Terni, Italy

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Approximately 10–20% of patients with non–small-cell lung cancer (NSCLC) harbor an epidermal growth factor receptor (EGFR) [...]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.